VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 179 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,687 | -24.1% | 6,409 | +15.7% | 0.00% | 0.0% |
| Q2 2023 | $36,495 | +182375.0% | 5,538 | +91.4% | 0.00% | 0.0% |
| Q1 2023 | $20 | +400.0% | 2,894 | +433.0% | 0.00% | – |
| Q4 2022 | $4 | -100.0% | 543 | -96.8% | 0.00% | -100.0% |
| Q3 2022 | $170,000 | -32.5% | 17,185 | -25.7% | 0.00% | -50.0% |
| Q2 2022 | $252,000 | +186.4% | 23,124 | +197.7% | 0.01% | +500.0% |
| Q1 2022 | $88,000 | -2.2% | 7,768 | +35.3% | 0.00% | -50.0% |
| Q4 2021 | $90,000 | -2.2% | 5,741 | +7.1% | 0.00% | 0.0% |
| Q3 2021 | $92,000 | +35.3% | 5,362 | +68.9% | 0.00% | 0.0% |
| Q2 2021 | $68,000 | -54.7% | 3,174 | -68.3% | 0.00% | -33.3% |
| Q1 2021 | $150,000 | +1775.0% | 9,999 | +1497.3% | 0.00% | – |
| Q4 2020 | $8,000 | -72.4% | 626 | -79.3% | 0.00% | – |
| Q3 2020 | $29,000 | -85.4% | 3,031 | -82.6% | 0.00% | -100.0% |
| Q2 2020 | $199,000 | +1709.1% | 17,444 | +2392.0% | 0.01% | +700.0% |
| Q4 2019 | $11,000 | -45.0% | 700 | -51.9% | 0.00% | 0.0% |
| Q2 2019 | $20,000 | +900.0% | 1,454 | +1590.7% | 0.00% | – |
| Q3 2018 | $2,000 | -75.0% | 86 | -79.3% | 0.00% | – |
| Q2 2018 | $8,000 | -78.9% | 416 | -81.4% | 0.00% | -100.0% |
| Q1 2018 | $38,000 | +22.6% | 2,232 | +11.0% | 0.00% | -25.0% |
| Q4 2017 | $31,000 | +287.5% | 2,011 | +333.4% | 0.00% | +300.0% |
| Q3 2017 | $8,000 | -50.0% | 464 | -50.9% | 0.00% | -50.0% |
| Q4 2016 | $16,000 | +1500.0% | 945 | +1475.0% | 0.00% | – |
| Q3 2016 | $1,000 | -50.0% | 60 | -65.1% | 0.00% | – |
| Q2 2016 | $2,000 | – | 172 | +5633.3% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 3 | -99.9% | 0.00% | -100.0% |
| Q3 2015 | $52,000 | +4.0% | 4,648 | +19.6% | 0.01% | +25.0% |
| Q2 2015 | $50,000 | -24.2% | 3,886 | -44.7% | 0.00% | -50.0% |
| Q1 2015 | $66,000 | +65.0% | 7,030 | +154.0% | 0.01% | +100.0% |
| Q4 2014 | $40,000 | +1900.0% | 2,768 | +1230.8% | 0.00% | – |
| Q3 2014 | $2,000 | -86.7% | 208 | -77.5% | 0.00% | -100.0% |
| Q2 2014 | $15,000 | -80.8% | 926 | -86.9% | 0.00% | -75.0% |
| Q3 2013 | $78,000 | – | 7,044 | +25057.1% | 0.01% | – |
| Q2 2013 | $0 | – | 28 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |